Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,248
Total Claims
$916K
Drug Cost
584
Beneficiaries
$1,569
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+31%
Opioid rate vs peers
3.4% vs 2.6% avg
+47%
Cost per patient vs peers
$1,569 vs $1,068 avg
+32%
Brand preference vs peers
11.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.4%
Opioid Rate
312
Opioid Claims
$5,846
Opioid Cost
3.8%
Long-Acting Rate
Brand vs Generic
Brand: 1,090 claims · $775K
Generic: 8,070 claims · $136K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 90 | $99K |
| Apixaban | 111 | $89K |
| Semaglutide | 39 | $54K |
| Insulin Aspart | 28 | $47K |
| Deutetrabenazine | 11 | $46K |
| Rifaximin | 12 | $40K |
| Dulaglutide | 35 | $37K |
| Tirzepatide | 30 | $35K |
| Rivaroxaban | 27 | $27K |
| Sitagliptin Phosphate | 31 | $26K |
| Fluticasone/Umeclidin/Vilanter | 21 | $25K |
| Mirabegron | 23 | $17K |
| Icosapent Ethyl | 30 | $13K |
| Insulin Lispro | 17 | $9,951 |
| Atorvastatin Calcium | 839 | $9,663 |
Prescribing Profile
Patient Profile
74
Avg Age
49%
Female
1.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About